Anavex appoints Robert Chisholm as CFO

Friday, June 29, 2012 11:01 AM

Anavex Life Sciences, a pharmaceutical company based in Vancouver, has appointed Robert Chisholm as chief financial officer.

Chisholm will remain on the Anavex board of directors, on which he has served since May 2011.  A veteran finance and administration executive with more than 25 years of experience, Chisholm has significant expertise in corporate finance, strategic business initiatives and the unique requirements of growth-oriented public companies. He also serves as a director and audit committee member for a number of other public companies.

Chisholm also currently serves as CFO and a director of both Savary Capital and OMT, CFO and a partner of Emprise Capital, CFO of TMT Resources and Ripper Oil and Gas, and member of the board of Rare Earth Industries.

Share:          
CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs